primary human retinal endothelial cells (ScienCell)
Structured Review

Primary Human Retinal Endothelial Cells, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human retinal endothelial cells/product/ScienCell
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Effect of ranibizumab on diabetic retinopathy via the vascular endothelial growth factor/STAT3/glial fibrillary acidic protein pathway"
Article Title: Effect of ranibizumab on diabetic retinopathy via the vascular endothelial growth factor/STAT3/glial fibrillary acidic protein pathway
Journal: World Journal of Diabetes
doi: 10.4239/wjd.v16.i5.99473
Figure Legend Snippet: Effect of ranibizumab on the viability of adult retinal pigment epithelial 19 cells and human retinal microvascular endothelial cells. Cell viability was assessed using the Cell Counting Kit-8 assay ( n = 3, independent experiments). A: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on adult retinal pigment epithelial 19 (ARPE-19) cell viability; B: Effect of ranibizumab (0 mg/mL, 0.0625 mg/mL, 0.125 mg/mL, or 025 mg/mL) treatment on human retinal microvascular endothelial cell (HRMEC) viability. All results are expressed as the mean ± SD. d P < 0.0001. 1 P vs 24 hour group. 2 P vs 48 hour group. NC: Untreated group.
Techniques Used: Cell Counting
Figure Legend Snippet: mRNA expression of vascular endothelial growth factor, interleukin 6, cluster of differentiation 18, intercellular adhesion molecule, tumor necrosis factor alpha, and signal transducer and activator of transcription 3 in adult retinal pigment epithelial 19 cells and human retinal microvascular endothelial cells. Untreated (NC) (5.5 mmol/L glucose), NC + ranibizumab (5.5 mmol/L glucose + 0.125 mg/mL ranibizumab), high glucose (Hg) (25 mmol/L glucose), and Hg + ranibizumab (25 mmol/L glucose + 0.125 mg/mL ranibizumab). A: Ratios of the mRNA expression of vascular endothelial growth factor (VEGF), interleukin 6 (IL-6), cluster of 18 differentiation (CD18), intercellular adhesion molecule (ICAM), tumor necrosis factor alpha (TNF-α), and signal transducer and activator of transcription 3 (STAT3) in different adult retinal pigment epithelial 19 (ARPE-19) groups; B: Ratios of mRNA expression of VEGF, IL-6, CD18, ICAM, TNF-α, and STAT3 in different human retinal microvascular endothelial cell (HRMEC) groups. All results are expressed as the mean ± SD. a P < 0.05. b P < 0.01. 1 P vs NC group. 2 P vs Hg group.
Techniques Used: Expressing
Figure Legend Snippet: Expression of glial fibrillary acidic protein, signal transducer and activator of transcription 3 (STAT3), and phosphorylated STAT3 proteins in adult retinal pigment epithelial 19 cells and human retinal microvascular endothelial cells. Untreated (NC) (5.5 mmol/L glucose), NC + ranibizumab (5.5 mmol/L glucose + 0.125 mg/mL ranibizumab), high glucose (Hg) (25 mmol/L glucose), and Hg + ranibizumab (25 mmol/L glucose + 0.125 mg/mL ranibizumab). A: Expression of glial fibrillary acidic protein (GFAP), signal transducer and activator of transcription 3 (STAT3), and phosphorylated STAT3 (pSTAT3) proteins in adult retinal pigment epithelial 19 (ARPE-19) cells were detected by Western blot analysis; B: Expression of GFAP, STAT3, and pSTAT3 proteins in human retinal microvascular endothelial cells (HRMECs) were detected by Western blot analysis; C: Ratios of GFAP, STAT3, and pSTAT3 protein expression levels in different groups of ARPE-19 cells; D: Ratios of GFAP, STAT3, and pSTAT3 protein expression levels in different groups of HRMECs. All results are expressed as the mean ± SD. a P < 0.05. b P < 0.01. 1 P vs NC group. 2 P vs Hg group.
Techniques Used: Expressing, Western Blot
Figure Legend Snippet: Ratio between the endothelial cell to pericyte ratio and the number of acellular strands. A: Ratio between the endothelial cell to pericyte (E/P) ratio and the number of acellular strands in each group revealed by retinal periodic acid-Schiff staining (magnification: 400 ×; scale bar: 2.5 μm); B and C: Ratio between E/P and the number of acellular strands during the sixth, eighth, and tenth weeks. The yellow arrows indicate the acellular strands, while the orange arrows indicate neovascularization bud. All results are expressed as the mean ± SD. a P < 0.05. b P < 0.01. 1 P vs F group. 2 P vs B group. 3 P vs D group.
Techniques Used: Staining
Figure Legend Snippet: mRNA expression of vascular endothelial growth factor, interleukin 6, cluster of differentiation 18, intercellular adhesion molecule, tumor necrosis factor-alpha, and signal transducer and activator of transcription 3 in the retinal tissues of Sprague-Dawley rats. A: Ratio of vascular endothelial growth factor (VEGF) mRNA expression in the retinal tissue of each group of Sprague-Dawley (SD) rats; B: Ratio of interleukin 6 (IL-6) mRNA expression in the retinal tissue of each group of SD rats; C: Ratio of cluster of differentiation 18 (CD18) mRNA expression in the retinal tissue of each group of SD rats; D: Ratio of intercellular adhesion molecule (ICAM) mRNA expression in the retinal tissue of each group of rats; E: Ratio of tumor necrosis factor alpha (TNF-a) mRNA expression in the retinal tissue of each group of rats; F: Ratio of signal transducer and activator of transcription 3 (STAT3) mRNA expression in the retinal tissue of each group of rats. All results are expressed as the mean ± SD. a P < 0.05. b P < 0.01. 1 P vs A group. 2 P vs B group. 3 P vs C group. 4 P vs D group. 5 P vs F group.
Techniques Used: Expressing